Merck Sharpe & Dohme Formulation Plant, Tuas, Singapore

Print

An atherosclerotic aorta caused by high cholesterol that may be prevented with the new combination treatment.
 
«Back

Return to Profile




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

The website for the pharmaceutical industry